Speaking Engagement Round Table Discussion: Litigation in an Age of Biologics Versus Biosimilars April 15, 2021 11:55 AM - 1:00 PM Virtual
Firm Announcements Walter Isaacson’s New Book “Code Breaker” about the inventors of CRISPR Technology features Sterne Kessler Director Eldora Ellison Sterne, Kessler, Goldstein & Fox P.L.L.C. March 17, 2021
Press Release Sterne Kessler Named Among 2021 "Best Law Firms" by Best Lawyers Sterne, Kessler, Goldstein & Fox November 6, 2020
Webinar Drug Development Pathway Series: Intellectual Property Workshop October 28, 2020 4:00 PM - 5:00 PM Virtual
Press Release Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings Sterne, Kessler, Goldstein & Fox P.L.L.C. October 6, 2020
Bylined Articles Patent License Considerations After Fed. Circ. Enbrel Ruling Law360 September 4, 2020 Eric K. Steffe Marsha Rose Gillentine, Ph.D.
Books and Chapters U.S. Biotechnology Patent Law, 2020-2021 Edition Thomson Reuters August 12, 2020 Jorge A. Goldstein, Ph.D.
Bylined Articles Biopharma Patentees Must Navigate Inherent Obviousness Law360 June 23, 2020 Eric K. Steffe Marsha Rose Gillentine, Ph.D. Pauline M. Pelletier
Bylined Articles INSIGHT: The Scope of a Sextillion—How Courts Misapply Law of Enablement to Life Sciences Bloomberg Law May 1, 2020 Paul A. Calvo, Ph.D. Kristina Caggiano Kelly
Bylined Articles Joint Research Considerations As Biotech Responds To Virus Law360 April 27, 2020 Eric K. Steffe Pauline M. Pelletier
Webinar Patents, Vaccines, and Viruses: A conversation about the role of IP in the age of COVID-19 April 16, 2020 11:00 AM - 12:00 PM
Bylined Articles Fed. Circ. Amgen Biosimilar Ruling Raises IP Damages Risk Law360 February 26, 2020 Paul A. Ainsworth Michael Bruns
Speaking Engagement International IP Skills Summit (IIPSS) February 26, 2020 - February 28, 2020 Hyderabad, India
In the News Federal Circuit Ruling Could Put Certain Drug Patents At Risk Bloomberg Law December 31, 2019
Books and Chapters U.S. Biotechnology Patent Law, 2019-2020 Edition Thomson Reuters November 1, 2019 Jorge A. Goldstein, Ph.D.